Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; deleted a government funding status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1. These changes do not affect study details or outcomes.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a 'Show glossary' option to the page. Updated metadata/labels: capitalization of 'Last Update Submitted that Met QC Criteria', the footer now displays 'No FEAR Act Data', and the site revision is updated to 'v3.4.0'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision changed from v3.3.3 to v3.3.4, indicating a small metadata update.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section listing study sites by state (Arizona, California, Colorado, Florida, Illinois, Iowa, Kentucky, Massachusetts, Missouri, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Washington, West Virginia) and updated to Revision: v3.3.3; removed the previous separate Arizona Locations, California Locations, etc.SummaryDifference2%

- Check91 days agoChange DetectedA Publications section wording change clarifies that PubMed-derived publications are auto-filled and may not all be about the study, and the footer revision indicator shows v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.